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Regulation of ENaCs by proteases: 
An increasingly complex story
TR Kleyman1, MM Myerburg1 and RP Hughey1
Proteolytic processing of epithelial Na+ channel (ENaC) subunits has 
an important role in the regulation of ENaC gating. This Commentary 
addresses the potential roles of specific proteases and protease 
inhibitors in the control of Na+ channel gating.
Kidney International (2006) 70, 1391–1392. doi:10.1038/sj.ki.5001860
Epithelial Na+ channels (ENaCs) have 
key roles in the regulation of urinary Na+ 
reabsorption, extracellular fl uid volume 
homeostasis, and control of blood pres-
sure and are a major target of action for 
volume-regulatory hormones such as 
aldosterone. Th ese channels also have an 
important role in the regulation of the vol-
ume of airway surface liquid and muco-
ciliary clearance. Na+ channel activity is 
regulated by two distinct mechanisms: 
(1) changes in single-channel gating (that 
is, open probability), or (2) changes in the 
number of Na+ channels expressed in the 
apical membrane. ENaCs are composed of 
three structurally related subunits, termed 
α, β, and γ. Th ese subunits have two mem-
brane-spanning domains connected by a 
large extracellular loop. Limited proteoly-
sis of ENaC α and γ subunits at specifi c 
sites within their extracellular domains 
has a key role in modulating channel gat-
ing (See Figure 1).1 Channels that lack 
proteolytic processing exhibit markedly 
reduced open probability because of inhi-
bition by external Na+, a process referred 
to as Na+ self-inhibition.1,2 Proteolytic 
processing of ENaC subunits within an 
individual channel complex is an all-or-
none event, and both proteolytically proc-
essed and non-processed subunits have 
been observed at the cell surface.3 Non-
processed, inactive channels present at the 
plasma membrane are thought to provide 
a reserve pool of channels that can be acti-
vated by proteases at the surface or within 
tubular fl uids.
Multiple proteases are involved in 
the proteolytic processing and activa-
tion of ENaC subunits. Furin is a serine 
protease that has been shown to have a 
physiologic role in the proteolytic process-
ing and activation of ENaC.1 As furin is 
localized primarily to the trans-Golgi 
network, it is likely that ENaC cleavage is 
occurring within the biosynthetic path-
way. Prostasin is a glycosyl phosphati-
dylinositol-anchored serine protease 
that has a physiologic role in activating 
ENaC.4,5 Prostasin as well as other pro-
teases may be processing and activating 
ENaCs at the cell surface. It is likely that 
a number of diff erent proteases may have 
roles in processing and activating ENaCs 
under normal physiologic conditions or 
in pathophysiologic states. For example, 
elastase may have a role in processing and 
activating ENaCs expressed in airways 
during states of infl ammation.6
Th e activation of channels by prote-
olysis requires that specific proteases 
are in an active state. Protease activity 
is modulated by a number of factors, 
including endogenous protease inhibi-
tors. Previous studies have demonstrated 
that ENaC activity is reduced by specifi c 
exogenous proteases. Both aprotinin, a 
prototypic Kunitz-type serine protease 
inhibitor, and the ectodomain of the 
human Kunitz-type inhibitor bikunin 
inhibit prostasin and reduce ENaC activ-
ity under specifi c conditions.4,7
Wakida et al.8 (this issue) address the 
role of an endogenous protease inhibi-
tor, protease nexin-1, in the modulation 
of ENaC activity. Th e authors confi rmed 
previous observations that co-expres-
sion of ENaC and prostasin in Xenopus 
oocytes enhances ENaC activity.4 Pro-
tease nexin-1 inhibits prostasin,9 and 
ENaC activation by prostasin was not 
observed in oocytes expressing protease 
nexin-1. Furthermore, ENaC activity was 
reduced in oocytes co-expressing ENaC 
and protease nexin-1, as compared with 
oocytes expressing ENaC alone. The 
results suggest that an endogenous pro-
tease nexin-1-sensitive enzyme has a role 
in modulating ENaC activity in oocytes.
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Figure 1 | ENaC is activated by proteolytic cleavage. ENaC is cleaved by furin twice in the 
α subunit and once in the γ subunit. The β subunit is not cleaved. ENaC is activated and is probably 
cleaved by other proteases, such as prostasin, that are inhibited by protease nexin-1 (PN-1).
1392   Kidney International (2006) 70
commentar y
see original article on page 1503
Is there a need to optimize 
glycemic control in hemodialyzed 
diabetic patients?
B Feldt-Rasmussen1
The report of Williams et al. gives rise to at least two important 
questions regarding diabetic patients on maintenance hemodialysis: 
(1) Does glycemic control play a significant role? (2) Is HbA1c a reliable 
measure of glycemic control? These questions are discussed. It is 
recommended that you treat ESRD patients with diabetes according to 
guidelines given for patients without ESRD.
Kidney International (2006) 70, 1392–1394. doi:10.1038/sj.ki.5001886
Th is month, Williams et al.1 (this issue) 
publish an interesting analysis of primary 
data on glycemic control and survival 
of diabetic patients from a large United 
States end-stage renal disease (ESRD) 
database. Patients were drawn from 
among 76 178 ESRD patients treated 
with hemodialysis at Fresenius Medical 
Care, North America, between 1 Octo-
ber and 31 December 2002. Among the 
many interesting results, I found three 
to be of particular interest. First, only a 
weak correlation between hemoglobin 
A1c (HbA1c) and random glucose values 
was observed. Second, the mean HbA1c 
among all type I and type II diabetic 
patients was very good, 6.77%, which is 
lower than normally observed in groups 
of diabetic patients without ESRD. 
Th ird, there was no correlation between 
HbA1c and survival at 12 months. Th is 
raises at least two important questions: 
(1) Does glycemic control play any 
signifi cant role in diabetic patients on 
maintenance hemodialysis? (2) Is HbA1c 
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A key question is whether endog-
enous protease nexin-1 modulates ENaC 
activity in the distal nephron. To begin 
to address this question, Wakida et al.8 
used small interfering RNA to partially 
knock down protease nexin-1 expression 
in the M1 mouse cortical collecting duct 
cell line. Th is was associated with a 60% 
increase in amiloride-sensitive equiva-
lent short circuit current, suggesting 
that endogenous protease nexin-1 has a 
role in modulating ENaC activity in M1 
cells. Furthermore, aldosterone reduced 
the expression of endogenous protease 
nexin-1 in M1 cells.
Volume depletion and aldosterone 
administration are associated with an 
increase in the proteolytic processing of 
ENaC subunits in rodent kidney.10,11 It 
has been proposed that an increase in the 
residency time of channels at the plasma 
membrane in response to aldosterone may 
contribute to the increase in ENaC subunit 
proteolysis, as non-cleaved channels at the 
plasma membrane will have more time to 
be processed by proteases.12 Altering the 
protease/protease inhibitor balance may 
also contribute to the increase in ENaC 
subunit proteolysis observed with volume 
depletion and aldosterone administra-
tion.13 Recent studies in airway epithelia 
are consistent with the notion that the rel-
ative protease/protease inhibitor balance 
may have an important role in determin-
ing the extent of proteolytic processing 
and activity of ENaCs.14 It is clear that 
the regulation of ENaCs by proteases is 
becoming an increasingly complex story.
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